Evidence map›Paper›PMID 26176698›Full record

ArticlePloS one2015

Humanized Chronic Graft-versus-Host Disease in NOD-SCID il2rγ-/- (NSG) Mice with G-CSF-Mobilized Peripheral Blood Mononuclear Cells following Cyclophosphamide and Total Body Irradiation.

Hisaki Fujii, Zhi-Juan Luo, Hye Jin Kim, Susan Newbigging, Adam Gassas, Armand Keating, R Maarten Egeler

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Fetal liver CD34Stem cell research & therapy · 2024
    Article
  7. Article
  8. [Effect of cyclophosphamide on hematopoietic stem cells in mice with iron overload].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
  9. Article
  10. Early myeloid-derived suppressor cells (HLA-DRJournal of hematology & oncology · 2019
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hisaki FujiiHematology/Oncology/BMT, The Hospital for Sick Children, Toronto, ON, Canada; Developmental Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, Canada.
Zhi-Juan LuoDevelopmental Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, Canada.
Hye Jin KimDevelopmental Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, Canada.
Susan NewbiggingToronto Centre for Phenogenomics, Toronto, ON, Canada.
Adam GassasHematology/Oncology/BMT, The Hospital for Sick Children, Toronto, ON, Canada.
Armand KeatingPrincess Margaret Hospital, Toronto, ON, Canada.
R Maarten EgelerHematology/Oncology/BMT, The Hospital for Sick Children, Toronto, ON, Canada; Developmental Stem Cell Biology, The Hospital for Sick Children, Toronto, ON, Canada.
Hospital for Sick Children · CAPrincess Margaret Cancer Centre · CAToronto Centre for Phenogenomics · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Humanized acute GvHD (aGvHD) in vivo models using NOD-SCID il2rγ-/- (NSG) mice are well described and are important tools for investigating pathogenicity of human cells in vivo. However, there have been only few reported humanized cGvHD mouse models. We evaluated if prolonged inflammation driven by low dose G-CSF-mobilized human PBMCs (G-hPBMCs) would lead to cGvHD following cyclophosphamide (CTX) administration and total body irradiation (TBI) in NSG mice. Engraftment was assessed in peripheral blood (PB) and in specific target organs by either flow cytometry or immunohistochemistry (IHC). Tissue samples were harvested 56 days post transplantation and were evaluated by a pathologist. Some mice were kept for up to 84 days to evaluate the degree of fibrosis. Mice that received CTX at 20mg/kg did not show aGvHD with stable expansion of human CD45+ CD3+ T-cells in PB (mean; 5.8 to 23.2%). The pathology and fibrosis scores in the lung and the liver were significantly increased with aggregation of T-cells and hCD68+ macrophages. There was a correlation between liver pathology score and the percentage of hCD68+ cells, suggesting the role of macrophage in fibrogenesis in NSG mice. In order to study long-term survival, 6/9 mice who survived more than 56 days showed increased fibrosis in the lung and liver at the endpoint, which suggests the infiltrating hCD68+ macrophages may be pathogenic. It was shown that the combination of CTX and TBI with a low number of G-hPBMCs (1x106) leads to chronic lung and liver inflammation driven by a high infiltration of human macrophage and mature human T cells from the graft, resulting in fibrosis of lung and liver in NSG mice. In conclusion this model may serve as an important pre-clinical model to further current understanding of the roles of human macrophages in cGvHD.

Indexed as

Hematopoietic Stem Cell MobilizationWhole-Body IrradiationAnimalsAntigens, CD34Bile DuctsChronic DiseaseCyclophosphamideFibrosisGraft vs Host DiseaseGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell TransplantationHumansInflammationLeukocytes, MononuclearLiverLungAntigens, CD34CyclophosphamideGranulocyte Colony-Stimulating Factor

Identifiers

PMID26176698
PMCPMC4503770
OpenAlexW1477104839

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.